Sanction Bid in Dismissed IP Case Still Valid, Sloan Says

By Andrew Strickler · January 20, 2017, 3:57 PM EST

A lawyer representing the Sloan Kettering Institute on Friday urged a New York federal judge to keep alive a sanction bid against counsel for a gene therapy company that sued the...

To view the full article, register now.

Documents

Case Information

Case Title

Errant Gene Therapeutics, LLC et al v. Sloan-Kettering Institute for Cancer Research

Case Number

1:15-cv-02044

Court

New York Southern

Nature of Suit

Patent

Date Filed

March 18, 2015